| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |